Brief: Inventiva: Cash, Cash Equivalents At EUR 107.8 Mln At End-March

Inventiva SA

13/05/2021 07:10

May 13 (Reuters) - Inventiva SA  IVAA.PA :
    * REPORTED ON WEDNESDAY Q1 REVENUE EUR 100,000, SIMILAR TO
AMOUNTS
RECEIVED IN Q1 2020
    * CASH AND CASH EQUIVALENTS AT EUR 107.8 MLN AS OF MARCH 31,
2021
VS EUR 113.0 MLN AS OF DEC 31, 2020    
    * DECISION BY ABBVIE  ABBV.N  TO MOVE INTO PHASE IIB
CLINICAL
DEVELOPMENT WITH CEDIROGANT IN PSORIASIS, PLANNED TO BE
INITIATED IN H2 2021
    * EXPECTS TO RECEIVE ANOTHER MILESTONE PAYMENT UPON
INITIATION BY
ABBVIE OF PHASE IIB CLINICAL TRIAL WITH CEDIROGANT

    
Source text for Eikon:  ID:nNDL44v5fN 
    
Further company coverage:  IVAA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))